BR0115393A - Derivados de benzodiazepina como moduladores de receptores gaba a - Google Patents

Derivados de benzodiazepina como moduladores de receptores gaba a

Info

Publication number
BR0115393A
BR0115393A BR0115393-5A BR0115393A BR0115393A BR 0115393 A BR0115393 A BR 0115393A BR 0115393 A BR0115393 A BR 0115393A BR 0115393 A BR0115393 A BR 0115393A
Authority
BR
Brazil
Prior art keywords
benzodiazepine
triazolo
imidazo
lower alkyl
oxadiazol
Prior art date
Application number
BR0115393-5A
Other languages
English (en)
Portuguese (pt)
Inventor
Raffaello Masciadri
Andrew William Thomas
Juergen Wichmann
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of BR0115393A publication Critical patent/BR0115393A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BR0115393-5A 2000-11-16 2001-11-08 Derivados de benzodiazepina como moduladores de receptores gaba a BR0115393A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00124332 2000-11-16
PCT/EP2001/012887 WO2002040487A2 (en) 2000-11-16 2001-11-08 Benzodiazepine derivatives as gaba a receptor modulators

Publications (1)

Publication Number Publication Date
BR0115393A true BR0115393A (pt) 2004-07-06

Family

ID=8170315

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0115393-5A BR0115393A (pt) 2000-11-16 2001-11-08 Derivados de benzodiazepina como moduladores de receptores gaba a

Country Status (40)

Country Link
US (1) US6743789B2 (enExample)
EP (1) EP1337535B1 (enExample)
JP (1) JP4088151B2 (enExample)
KR (1) KR100504300B1 (enExample)
CN (1) CN1191255C (enExample)
AR (1) AR031345A1 (enExample)
AT (1) ATE268776T1 (enExample)
AU (2) AU1700702A (enExample)
BG (1) BG107817A (enExample)
BR (1) BR0115393A (enExample)
CA (1) CA2427576C (enExample)
CZ (1) CZ295256B6 (enExample)
DE (1) DE60103776T2 (enExample)
DK (1) DK1337535T3 (enExample)
EC (1) ECSP034607A (enExample)
ES (1) ES2220831T3 (enExample)
GC (1) GC0000375A (enExample)
GT (1) GT200100230A (enExample)
HR (1) HRP20030360A2 (enExample)
HU (1) HUP0303281A3 (enExample)
IL (1) IL155813A0 (enExample)
JO (1) JO2359B1 (enExample)
MA (1) MA26962A1 (enExample)
MX (1) MXPA03004251A (enExample)
MY (1) MY141675A (enExample)
NO (1) NO324706B1 (enExample)
NZ (1) NZ525413A (enExample)
PA (1) PA8532401A1 (enExample)
PE (1) PE20020583A1 (enExample)
PL (1) PL362925A1 (enExample)
PT (1) PT1337535E (enExample)
RU (1) RU2278865C2 (enExample)
SI (1) SI1337535T1 (enExample)
SK (1) SK7232003A3 (enExample)
TR (1) TR200402073T4 (enExample)
TW (1) TWI239333B (enExample)
UY (1) UY27026A1 (enExample)
WO (1) WO2002040487A2 (enExample)
YU (1) YU35603A (enExample)
ZA (1) ZA200303435B (enExample)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6686352B2 (en) * 2001-05-18 2004-02-03 Hoffmann-La Roche Inc. Substituted imidazo [1,5-a] pyrimido [5,4-d] [1] benzazepine derivatives
WO2004113321A1 (ja) * 2003-06-19 2004-12-29 Daiichi Pharmaceutical Co., Ltd. 選択的なアミノ置換基導入法
WO2005060968A1 (en) 2003-12-11 2005-07-07 Sepracor Inc. Combination of a sedative and a neurotransmitter modulator, and methods for improving sleep quality and treating depression
CA2577060A1 (en) 2004-08-13 2006-02-23 Amgen Inc. Substituted benzofused heterocycles
DE602005008633D1 (de) * 2004-10-12 2008-09-11 Hoffmann La Roche Imidazoä1,5aütriazoloä1,5dübenzodiazepin-derivative zur behandlung kognitiver störungen
JP4783375B2 (ja) 2004-10-20 2011-09-28 エフ.ホフマン−ラ ロシュ アーゲー イミダゾベンゾジゼピン誘導体
MX2007004640A (es) * 2004-10-20 2007-06-08 Hoffmann La Roche Derivados de benzodiazepina sustituidos con halogeno.
ES2307230T3 (es) * 2004-12-14 2008-11-16 F. Hoffmann-La Roche Ag Imidazo-benzodiacepinas tetraciclicas como moduladores de los receptores gaba.
EP2682481A3 (en) * 2005-08-03 2014-09-17 The Johns-Hopkins University Methods for characterizing and treating cognitive impairment in aging and disease
US8510055B2 (en) 2005-08-03 2013-08-13 The Johns Hopkins University Methods for characterizing and treating cognitive impairment in aging and disease
ATE477255T1 (de) * 2005-10-11 2010-08-15 Hoffmann La Roche Imidazobenzdiazepinderivate
WO2007053596A1 (en) 2005-10-31 2007-05-10 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US9156836B2 (en) * 2008-05-16 2015-10-13 Synta Pharmaceuticals Corp. Tricyclic triazole compounds that modulate HSP90 activity
PL2358714T3 (pl) * 2008-11-18 2012-12-31 Hoffmann La Roche Etery alkilocykloheksylowe dihydrotetraazabenzoazulenu
SG171846A1 (en) * 2008-11-28 2011-07-28 Hoffmann La Roche Arylcyclohexylethers of dihydrotetraazabenzoazulenes for use as vasopressin via receptor antagonists
CU20090172A6 (es) 2009-10-09 2011-10-05 Facultad De Quimica Universidad De La Habana Sistemas tricíclicos y tetracíclicos con actividad sobre el sistema nervioso central y vascular
DK3034079T3 (en) 2010-11-15 2018-02-05 Agenebio Inc PYRIDAZINE DERIVATIVES, COMPOSITIONS AND PROCEDURES FOR TREATING COGNITIVE WEAKNESS
US20150374705A1 (en) 2012-02-14 2015-12-31 Shanghai Institues for Biological Sciences Substances for treatment or relief of pain
JP2015529254A (ja) * 2012-09-21 2015-10-05 ユーダブリューエム・リサーチ・ファウンデーション,インコーポレーテッド 喘息における気道の過敏症及び炎症を制御するための新規なgabaaアゴニスト及び使用方法
CN112409363B (zh) * 2013-12-20 2023-11-14 艾吉因生物股份有限公司 用于治疗认知损害的苯并二氮杂䓬衍生物、组合物和方法
WO2016205739A1 (en) 2015-06-19 2016-12-22 Belew Mekonnen Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
US10059718B2 (en) * 2016-01-04 2018-08-28 Tabomedex Biosciences, LLC Fused quadracyclic compounds, compositions and uses thereof
US10973479B2 (en) 2016-05-16 2021-04-13 Canon Medical Systems Corporation X-ray diagnosis apparatus, X-ray diagnosis apparatus controlling method, and X-ray diagnosis system
US11505555B2 (en) 2016-12-19 2022-11-22 Agenebio, Inc. Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
US20180170941A1 (en) * 2016-12-19 2018-06-21 Agenebio, Inc. Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
KR102512548B1 (ko) 2017-12-22 2023-03-22 삼성디스플레이 주식회사 유기 전계 발광 소자 및 유기 전계 발광 소자용 함질소 화합물
BR112020026062B1 (pt) * 2018-06-19 2023-04-04 Agenebio, Inc Compostos derivados de benzodiazepina ou um sal farmaceuticamente aceitavel, isômero ou combinação dos mesmos, composição farmacêutica compreendendo os mesmos e usos dos mesmos para o tratamento de comprometimento cognitivo, câncer cerebral e psicose da doença de parkinson
KR102151969B1 (ko) * 2019-12-11 2020-09-04 주식회사 지투비 투과도 가변창의 제조방법 및 그에 의해 제조된 투과도 가변창
CN112979658B (zh) * 2021-02-22 2022-05-31 南湖实验室 一种氟马西尼的制备方法
US20240132513A1 (en) 2022-08-19 2024-04-25 Agenebio, Inc. Benzazepine derivatives, compositions, and methods for treating cognitive impairment

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK174086D0 (da) 1986-04-16 1986-04-16 Ferrosan As Nye benzodiazepinderivater samt fremgangsmaade til fremstilling af samme
TW201311B (enExample) 1991-06-17 1993-03-01 Hoffmann La Roche

Also Published As

Publication number Publication date
PL362925A1 (en) 2004-11-02
KR100504300B1 (ko) 2005-07-28
HK1062442A1 (en) 2004-11-05
KR20030045192A (ko) 2003-06-09
ATE268776T1 (de) 2004-06-15
TWI239333B (en) 2005-09-11
US20020103371A1 (en) 2002-08-01
CZ295256B6 (cs) 2005-06-15
WO2002040487A2 (en) 2002-05-23
CN1191255C (zh) 2005-03-02
US6743789B2 (en) 2004-06-01
MXPA03004251A (es) 2003-09-22
PA8532401A1 (es) 2002-08-26
NO20032208L (no) 2003-05-15
AU2002217007B2 (en) 2006-11-30
NZ525413A (en) 2005-02-25
TR200402073T4 (tr) 2004-10-21
YU35603A (sh) 2006-05-25
MA26962A1 (fr) 2004-12-20
ES2220831T3 (es) 2004-12-16
CN1474820A (zh) 2004-02-11
DK1337535T3 (da) 2004-10-25
HRP20030360A2 (en) 2005-04-30
MY141675A (en) 2010-06-15
NO20032208D0 (no) 2003-05-15
UY27026A1 (es) 2002-06-20
SI1337535T1 (en) 2004-10-31
AU1700702A (en) 2002-05-27
GC0000375A (en) 2007-03-31
BG107817A (bg) 2004-07-30
AR031345A1 (es) 2003-09-17
JP2004517070A (ja) 2004-06-10
JP4088151B2 (ja) 2008-05-21
GT200100230A (es) 2002-07-04
CZ20031597A3 (cs) 2003-11-12
EP1337535B1 (en) 2004-06-09
DE60103776D1 (de) 2004-07-15
JO2359B1 (en) 2006-12-12
WO2002040487A3 (en) 2002-09-26
HUP0303281A3 (en) 2005-05-30
EP1337535A2 (en) 2003-08-27
IL155813A0 (en) 2003-12-23
ZA200303435B (en) 2004-08-05
HUP0303281A2 (hu) 2004-01-28
PE20020583A1 (es) 2002-07-06
NO324706B1 (no) 2007-12-03
DE60103776T2 (de) 2005-07-14
ECSP034607A (es) 2003-06-25
SK7232003A3 (en) 2004-03-02
PT1337535E (pt) 2004-09-30
RU2278865C2 (ru) 2006-06-27
CA2427576A1 (en) 2002-05-23
CA2427576C (en) 2007-11-06
RU2003116895A (ru) 2005-02-20

Similar Documents

Publication Publication Date Title
AR031345A1 (es) Derivados de benzodiazepina como moduladores receptores gaba a
CN113226356B (zh) 活化丙酮酸激酶r
KR20100050459A (ko) 치환된 이미다조헤테로사이클
CN101228167A (zh) 作为蛋白激酶抑制剂的吡唑并[1,5-a]嘧啶-7-基-胺衍生物
RU2011117412A (ru) Трициклические оксазолидиноновые антибиотические соединения
RU2006129324A (ru) Конденсированные гетероциклические соединения и их применение в качестве антагонистов метаботропных глутаматных рецепторов
JP2004517070A5 (enExample)
BR0209859A (pt) Derivados de imidazo[1,5-a]pirimido[5-4-d][1]benzazepina como moduladores de receptores de gaba a
AU2002217007A1 (en) Benzodiazepine derivatives as GABA A receptor modulators
TW201041893A (en) Modulators of 5-HT receptors and methods of use thereof
BR112016024455B1 (pt) Composto heterocíclico bicíclico ou tricíclico
FR2792938A1 (fr) NOUVELLES 1-AMINO TRIAZOLO [4,3-a] QUINAZOLINE-5-ONES INHIBITRICES DE PHOSPHODIESTERASES IV
WO2011077098A1 (en) Inhibitors of akt activity
PE20041057A1 (es) Derivados de azabiciclos sustituidos de piridiloximetilo y bencisoxazol
BRPI0513084A (pt) antagonistas duplos de nk1/nk3 contra esquizofrenia
BR0213177A (pt) Derivados de 5-metóxi-8-aril-[1,2,4]triazolo[1,5-a]piridina
BRPI0515800A (pt) imidazo-benzodiazepinas tetracìclicas como moduladores de receptores de gaba
ATE337827T1 (de) N-aryl-4,5-diaminopyrazole und diese verbindungen enthaltende färbemittel
NO20005390D0 (no) Nye forbindelser av 9-(3,5-dimetyloksyfenyl)-5,8,8a,9- tetrahydrofuro[3',4':6,7]nafto[2,3-d]-[1,3]dioksol-6(5aH)-on, fremgangsmÕte ved deres fremstilling og farmasøytiske sammensetninger inneholdende dem
DK1202977T3 (da) Fremgangsmåde til fremstilling af diazepinderivater
TH82916A (th) อนุพันธ์ไตรไซคลิก อะโซล, การผลิตของมันและการใช้เป็นสารกระทำทางเภสัชกรรม
TH67156A (th) อนุพันธ์ของเบนโซไดอะพีนในฐานะของตัวปรับตัวรับ gaba a
TH80294A (th) ไบ-และไทรไซคลิค ซับสทิทิวเทด เฟนิล เมธาโนน
TH81783A (th) เททราไฮโดร-พิริโดแอซีพิน-8-โอน และสารประกอบที่เกี่ยวข้องสำหรับการบำบัดโรคจิตเภท

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: PARA:INT.CI. C07D 487/14, A61K 31/55, A61K 31/5517, A61P 25/00, A61P 25/28, A61P 43/00

Ipc: C07D 487/14 (2006.01), A61K 31/55 (2006.01), A61K

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 10A ANUIDADE(S).

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2129 DE 25/10/2011.